Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 218 participants.
Also called NCT06441539
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 218 participants
- Sponsor
- Yinyi(Liaoning) Biotech Co., Ltd.
- Registry
-
NCT06441539
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06441539. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2025-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Bingo® Paclitaxel coated balloon
- Intervention (Device)
- Xience® Alpine Everolimus Eluting Coronary Stent System
- Lead sponsor
- Yinyi(Liaoning) Biotech Co., Ltd.
Record details
- Record id
cardio:ct-nct06441539- Content hash
4fce3630a91a3761eccca091d8d16d448c2399f84023bb5f68176f012087893a